
Foldexis is a synthetic protein biology company focused on advancing protein design technologies through machine learning and computational biology. They specialize in protein structure prediction and protein-ligand interaction design, aiming to create custom-designed proteins for medical applications, including the treatment of diseases like cancer. Their approach leverages both open-source and proprietary modeling tools, incorporating principles of biophysics and metabolic biochemistry with large-scale computing. Foldexis collaborates with research companies to develop advanced proteins and is involved with the RosettaCommons initiative and the Foldit game to aid in protein folding research.

Foldexis is a synthetic protein biology company focused on advancing protein design technologies through machine learning and computational biology. They specialize in protein structure prediction and protein-ligand interaction design, aiming to create custom-designed proteins for medical applications, including the treatment of diseases like cancer. Their approach leverages both open-source and proprietary modeling tools, incorporating principles of biophysics and metabolic biochemistry with large-scale computing. Foldexis collaborates with research companies to develop advanced proteins and is involved with the RosettaCommons initiative and the Foldit game to aid in protein folding research.